Cravatex Ltd

As of 17-Nov, Cravatex Ltd's stock price is at 399.50, up 4.84% today, but down 9.40% year-to-date. The stock shows strong short-term performance, outperforming the Sensex, though it has faced significant declines over the past year and a drop in delivery volume.

Cravatex has experienced significant declines in net sales and profitability, with net sales dropping from 594.33 Cr in Mar'22 to 173.76 Cr in Mar'25, and operating profit margins turning negative. Despite a reduction in total liabilities, the company has struggled to maintain revenue and profitability over recent years.

As of 10-Nov, Cravatex Ltd's stock price is Rs 370.20, down 7.16%, with significant volatility and underperformance against its sector. The stock has declined 6.86% over the past week and 16.04% year-to-date, reflecting weak investor confidence amid broader market stability.

The next results date for Cravatex is 14 November 2025.

As of 24-Oct, Cravatex Ltd's stock price is at 410.00, showing a slight increase and a significant rise in delivery volume, indicating increased investor interest. Despite outperforming the Sensex in the short term, the stock has underperformed over longer periods and remains below key moving averages.

As of 15-Oct, Cravatex Ltd's stock price is at 388.00, down 0.6%, and has underperformed significantly with a year-to-date return of -12.01%. Despite increased investor participation, the stock remains in a bearish trend, contrasting sharply with the positive performance of the Sensex.

As of 29-Sep, Cravatex Ltd's stock price is at 418.50, up 1.97% recently, but it has a year-to-date decline of 5.09% and a one-year return of -14.93%. The company faces significant financial challenges, including operating losses and a negative EBITDA, which may limit its long-term performance despite recent short-term gains.

As of 25-Sep, Cravatex Ltd's stock price is Rs 394.10, down 5.04% and underperforming its sector. The company faces significant financial challenges, including operating losses and declining investor confidence, leading to a total decline of 14.06% over the past month.

As of 24-Sep, Cravatex Ltd's stock price is at 415.00, down 1.0 (-0.24%), and has declined -2.12% over the last two days. The stock is trading below all major moving averages, indicating a bearish trend, and has significantly decreased delivery volume, reflecting reduced investor participation.

As of 23-Sep, Cravatex Ltd's stock price is at 416.00, down 1.89%, and has underperformed its sector. The company faces operational losses and declining investor interest, contributing to a bearish trend and significant underperformance compared to market benchmarks.

Cravatex has experienced significant financial declines, with net sales dropping from 594.33 Cr in March 2022 to 173.76 Cr in March 2025, and a negative operating profit since March 2023. Despite reduced expenditures and liabilities, the company faces challenges in revenue generation and profitability, reflected in a declining net profit margin.

Cravatex has experienced significant declines in net sales and profitability, with net sales dropping from 594.33 Cr in March 2022 to 173.76 Cr in March 2025, and a decrease in total assets from 441.91 Cr to 140.70 Cr during the same period. Operating profit fluctuated, with a loss of 30.34 Cr in March 2023 turning into a slight profit of 8.26 Cr by March 2025, reflecting ongoing financial challenges.

As of 12-Aug, Cravatex Ltd's stock price is at 485.00, up 1.68%, but the company faces significant challenges including operating losses and a poor EBIT to Interest ratio. Despite a short-term price increase, long-term fundamentals and declining profit raise concerns about its financial health.

Cravatex's latest results show a 19.42% year-over-year growth in net sales and a significant 188% increase in consolidated net profit, indicating positive trends. However, the company's heavy reliance on non-operating income raises concerns about its long-term financial sustainability.

As of 11-Aug, Cravatex Ltd's stock price is at 477.00, down 0.81%. The stock has weak fundamentals, underperformed its sector and the Sensex, and shows significant declines in both recent performance and investor participation.

As of 08-Aug, Cravatex Ltd's stock price is at 480.90, showing a 0.4% increase and outperforming its sector. Despite a decline in investor participation, the stock has performed better than the Sensex in the short term, though it faces longer-term challenges with a one-year return down by 6.62%.